Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide

A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis. A...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical case reports Vol. 9; no. 7; pp. e04300 - n/a
Main Authors:	Hashimoto, Akiko, Tanaka, Yasuhiro, Shinzato, Isaku
Format:	Journal Article
Language:	English
Published:	England John Wiley & Sons, Inc 01-07-2021 John Wiley and Sons Inc Wiley
Subjects:	acute promyelocytic leukemia Arsenic arsenic trioxide Blood Bone marrow Case Report Case reports chronic kidney disease Electrocardiography Hematology Hemodialysis Hypoxia Kidney diseases Leukemia Medical prognosis Patients Remission (Medicine) Japan arsenic trioxide chronic kidney disease acute promyelocytic leukemia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis. A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.4300